E Fund Management’s Global Blood Therapeutics, Inc. GBT Stock Holding History

E Fund Management’s Portfolio GBT Stock Details GBT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-7,030	Closed	-$479K	–	362
2022 Q3	$479K	Sell	7,030 -12,319	-64%	-$679K	0.04%	131
2022 Q2	$618K	Buy	19,349 +9,703	+101%	+$284K	0.06%	117
2022 Q1	$334K	Buy	+9,646	New	+$288K	0.01%	172

Other funds holding GBT

BTI

Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

E Fund Management's GBT Position: Q4 2022 in Review

E Fund Management sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 7,030 shares — an estimated $479K sold.

E Fund Management first reported a position in GBT in Q1 2022 and held it in 3 quarters. The position peaked at $618K in Q2 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

E Fund Management reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
E Fund Management sold 7,030 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $479K.
E Fund Management first reported a position in Global Blood Therapeutics, Inc. in Q1 2022 and held it in 3 quarters.
E Fund Management's Global Blood Therapeutics, Inc. position peaked at $618K in Q2 2022.
2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on E Fund Management's 13F filing for Q4 2022, filed 14 Feb 2023.